NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis

作者：Linjuan Sun, Nan Ouyang, Shaheryar Shafi, Rongchuan Zhao, Jinlin Pan, Hong Lei, Xueyan Song, Xiaohan Sa, Yuanshuai Zhou · 发表于：Technology in Cancer Research & Treatment · 年份：2023 · DOI：10.1177/15330338231161141 · 被引用次数：9 · 研究领域：Genomics, phytochemicals, and oxidative stress、RNA modifications and cancer、Epigenetics and DNA Methylation

Introduction: Nuclear respiratory factor 1 (NRF1) is an important regulator involved in mitochondrial biogenesis and energy metabolism. However, the specific mechanism of NRF1 in anoikis and epithelial-mesenchymal transition (EMT) remains unclear. Methods: We examined the effect of NRF1 on mitochondria and identified the specific mechanism through transcriptome sequencing, and explored the relationships among NRF1, anoikis, and EMT. Results: We found that upregulated NRF1 expression led to increased mitochondrial oxidative phosphorylation (OXPHOS) and ATP generation. Simultaneously, a significant amount of ROS is generated during OXPHOS. Alternatively, NRF1 upregulates the expression of ROS-scavenging enzymes, allowing tumor cells to maintain low ROS levels and promoting anoikis resistance and EMT. We also found that exogenous ROS was maintained at a low level by NRF1 in breast cancer cells. Conclusion: our study provides mechanistic insight into the function of NRF1 in breast cancer, indicating that NRF1 may serve as a therapeutic target for breast cancer treatment.